Suppr超能文献

高渗性与钙螯合作用:对囊性纤维化黏液的影响

Hyper-osmolarity and calcium chelation: Effects on cystic fibrosis mucus.

作者信息

Ermund Anna, Meiss Lauren N, Gustafsson Jenny K, Hansson Gunnar C

机构信息

Department of Medical Biochemistry, University of Gothenburg, Medicinaregatan 9A, SE-413 90 Gothenburg, Sweden.

Department of Medical Biochemistry, University of Gothenburg, Medicinaregatan 9A, SE-413 90 Gothenburg, Sweden.

出版信息

Eur J Pharmacol. 2015 Oct 5;764:109-117. doi: 10.1016/j.ejphar.2015.06.051. Epub 2015 Jun 30.

Abstract

A non-functional Cystic Fibrosis Transmembrane conductance Regulator (CFTR) leads to the disease cystic fibrosis (CF). Although the CFTR is expressed in multiple organs, pulmonary disease is the major cause of illness and death in patients with CF. Stagnant mucus, causing airway obstruction, bacterial overgrowth, persistent inflammation and tissue destruction characterizes the disease, but how the defect in CFTR function is coupled to the mucus phenotype is still controversial. We have recently shown that bicarbonate ions passing through CFTR are necessary for proper unfolding of the MUC2 mucin, thus highlighting the importance of bicarbonate ion transport via the CFTR and the ability of these ions to raise the pH and chelate calcium bound to the mucin as the important steps in forming normal mucus. In order to find potential CF treatments and expand our knowledge about the usefulness of bicarbonate as an active ingredient in formulations to alleviate mucus plugging, we used an Ussing-type chamber and explants from the F508del-CFTR mutant mouse ileum to test the effect of calcium chelators on mucus attachment, either in isolation or in combination with osmolytes such as mannitol or hypertonic saline. We found that increasing the concentration of bicarbonate, both alone or in combination with increased osmolarity of the solution, detached the otherwise attached CF mucus.

摘要

无功能的囊性纤维化跨膜传导调节因子(CFTR)会导致囊性纤维化(CF)疾病。尽管CFTR在多个器官中表达,但肺部疾病是CF患者发病和死亡的主要原因。黏液停滞导致气道阻塞、细菌过度生长、持续性炎症和组织破坏是该疾病的特征,但CFTR功能缺陷如何与黏液表型相关联仍存在争议。我们最近发现,通过CFTR的碳酸氢根离子对于MUC2黏蛋白的正确展开是必需的,从而突出了通过CFTR进行碳酸氢根离子转运以及这些离子提高pH值和螯合与黏蛋白结合的钙的能力在形成正常黏液过程中的重要步骤。为了寻找潜在的CF治疗方法,并扩展我们对碳酸氢根作为减轻黏液阻塞配方中的活性成分的有用性的认识,我们使用了尤斯灌流室和来自F508del-CFTR突变小鼠回肠的外植体,来测试钙螯合剂单独或与诸如甘露醇或高渗盐水等渗透剂联合使用时对黏液附着的影响。我们发现,单独增加碳酸氢根浓度或与溶液渗透压增加联合使用,均可使原本附着的CF黏液分离。

相似文献

1
Hyper-osmolarity and calcium chelation: Effects on cystic fibrosis mucus.
Eur J Pharmacol. 2015 Oct 5;764:109-117. doi: 10.1016/j.ejphar.2015.06.051. Epub 2015 Jun 30.
2
New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition.
Eur J Pharmacol. 2021 Aug 5;904:174123. doi: 10.1016/j.ejphar.2021.174123. Epub 2021 May 8.
4
Hypertonic saline releases the attached small intestinal cystic fibrosis mucus.
Clin Exp Pharmacol Physiol. 2015 Jan;42(1):69-75. doi: 10.1111/1440-1681.12322.
5
OligoG CF-5/20 normalizes cystic fibrosis mucus by chelating calcium.
Clin Exp Pharmacol Physiol. 2017 Jun;44(6):639-647. doi: 10.1111/1440-1681.12744.
6
Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties hydration.
Eur Respir J. 2022 Feb 3;59(2). doi: 10.1183/13993003.00185-2021. Print 2022 Feb.
7
Bicarbonate in cystic fibrosis.
J Cyst Fibros. 2017 Nov;16(6):653-662. doi: 10.1016/j.jcf.2017.06.005. Epub 2017 Jul 18.
8
Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion.
J Clin Invest. 2009 Sep;119(9):2613-22. doi: 10.1172/JCI38662. Epub 2009 Aug 24.
9
Novel Therapy of Bicarbonate, Glutathione, and Ascorbic Acid Improves Cystic Fibrosis Mucus Transport.
Am J Respir Cell Mol Biol. 2020 Sep;63(3):362-373. doi: 10.1165/rcmb.2019-0287OC.
10
CFTR, mucins, and mucus obstruction in cystic fibrosis.
Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a009589. doi: 10.1101/cshperspect.a009589.

引用本文的文献

1
Metachrony drives effective mucociliary transport via a calcium-dependent mechanism.
Am J Physiol Lung Cell Mol Physiol. 2024 Sep 1;327(3):L282-L292. doi: 10.1152/ajplung.00392.2023. Epub 2024 Jun 11.
2
Pancreatic enzymes digest obstructive meconium from cystic fibrosis pig intestines.
Front Pediatr. 2024 Apr 11;12:1387171. doi: 10.3389/fped.2024.1387171. eCollection 2024.
3
Specialized proresolving mediator resolvin E1 corrects the altered cystic fibrosis nasal epithelium cilia beating dynamics.
Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2313089121. doi: 10.1073/pnas.2313089121. Epub 2024 Jan 22.
4
Advances in the Cystic Fibrosis Drug Development Pipeline.
Life (Basel). 2023 Aug 30;13(9):1835. doi: 10.3390/life13091835.
5
New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition.
Eur J Pharmacol. 2021 Aug 5;904:174123. doi: 10.1016/j.ejphar.2021.174123. Epub 2021 May 8.
6
Mucins and the Microbiome.
Annu Rev Biochem. 2020 Jun 20;89:769-793. doi: 10.1146/annurev-biochem-011520-105053. Epub 2020 Apr 3.
7
Mucus, mucins, and cystic fibrosis.
Pediatr Pulmonol. 2019 Nov;54 Suppl 3(Suppl 3):S84-S96. doi: 10.1002/ppul.24530.
9
Development of an airway mucus defect in the cystic fibrosis rat.
JCI Insight. 2018 Jan 11;3(1). doi: 10.1172/jci.insight.97199.
10
Mucus models to evaluate the diffusion of drugs and particles.
Adv Drug Deliv Rev. 2018 Jan 15;124:34-49. doi: 10.1016/j.addr.2017.11.001. Epub 2017 Nov 5.

本文引用的文献

1
Therapeutic options for hydrating airway mucus in cystic fibrosis.
Pharmacology. 2015;95(3-4):117-32. doi: 10.1159/000377638. Epub 2015 Mar 19.
2
Hypertonic saline releases the attached small intestinal cystic fibrosis mucus.
Clin Exp Pharmacol Physiol. 2015 Jan;42(1):69-75. doi: 10.1111/1440-1681.12322.
3
Microbial-induced meprin β cleavage in MUC2 mucin and a functional CFTR channel are required to release anchored small intestinal mucus.
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12396-401. doi: 10.1073/pnas.1407597111. Epub 2014 Aug 11.
4
Mucociliary clearance: pathophysiological aspects.
Clin Physiol Funct Imaging. 2014 May;34(3):171-7. doi: 10.1111/cpf.12085. Epub 2013 Sep 30.
5
Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
Cochrane Database Syst Rev. 2013 Jul 12;2013(7):CD007168. doi: 10.1002/14651858.CD007168.pub3.
7
Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.
Thorax. 2013 Dec;68(12):1157-62. doi: 10.1136/thoraxjnl-2013-203204. Epub 2013 May 23.
8
Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth.
Aliment Pharmacol Ther. 2013 Jun;37(11):1103-11. doi: 10.1111/apt.12304. Epub 2013 Apr 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验